The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Expanding Criteria for Resectability of Colorectal Liver Metastases
Abstract
Learning Objectives: After completing this course, the reader will be able to: Identify the criteria for hepatic resection of colorectal metastases.Describe strategies for expanding the number of patients who may potentially benefit from hepatic resection.List the factors associated with poor prognosis following hepatic resection. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com Surgical resection is the treatment of choice in patients with colorectal liver metastases, with 5-year survival rates reported in the range of 40%–58%. Over the past 10 years, there has been an impetus to expand the criteria for defining resectability for patients with colorectal metastases. In the past, such features as the number of metastases (three to four), the size of the tumor lesion, and a mandatory 1-cm margin of resection dictated who was “resectable.” More recently, the criteria for resectability have been expanded to include any patient in whom all disease can be removed with a negative margin and who has adequate hepatic volume/reserve. Specifically, instead of resectability being defined by what is removed, decisions concerning resectability now center around what will remain after resection. Under this new paradigm, the number of patients with resectable disease can be expanded by increasing/preserving hepatic reserve (e.g., portal vein embolization, two-stage hepatectomy), combining resection with ablation, and decreasing tumor size (preoperative chemotherapy). The criteria for resectability have also expanded to include patients with extrahepatic disease. Rather than being an absolute contraindication to surgery, patients with both intra- and extrahepatic disease should potentially be considered for resection based on strict selection criteria. The expansion of criteria for resectability of colorectal liver metastases requires a much more nuanced and sophisticated approach to the patient with advanced disease. A therapeutic approach that includes all aspects of multidisciplinary and multimodality care is required to select and treat this complex group of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Douillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256
Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.113 · Cited by 2,915
Cunningham, D., Pyrhönen, S., James, R. D., Punt, C. J., Hickish, T. F., Heikkila, R., Johannesen, T. B., Starkhammar, H., Topham, C. A., Awad, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02309-5 · Cited by 1,259
Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer
Kobayashi, K., Kawamura, M., & Ishihara, T. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70106-6 · Cited by 152
Cited by
de Jong, M. C., Pulitano, C., Ribero, D., Strub, J., Mentha, G., Schulick, R. D., Choti, M. A., Aldrighetti, L., Capussotti, L., & Pawlik, T. M. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b4539b · Cited by 783
Self-citationSasaki, K., Morioka, D., Conci, S., Margonis, G. A., Sawada, Y., Ruzzenente, A., Kumamoto, T., Iacono, C., Andreatos, N., Guglielmi, A., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002064 · Cited by 472
Self-citationRisk of Morbidity and Mortality Following Hepato-Pancreato-Biliary Surgery
Kneuertz, P. J., Pitt, H. A., Bilimoria, K. Y., Smiley, J. P., Cohen, M. E., Ko, C. Y., & Pawlik, T. M. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-1938-y · Cited by 276
Self-citationMurtha-Lemekhova, A., Fuchs, J., Ghamarnejad, O., Nikdad, M., Probst, P., & Hoffmann, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-92888-4 · Cited by 36
Metadata
- Authors
- Pawlik, T. M., Schulick, R. D., & Choti, M. A.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-01
- Volume
- 13
- Issue
- 1
- Pages
- 51-64
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2158918006
- Cited by
- 449
- References
- 5
- FWCI
- 15.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expanding Criteria for Resectability of Colorectal Liver Metastases. https://app.cochat.ai/papers/10.1634/theoncologist.2007-0142
- The paper
- Pawlik, T. M., Schulick, R. D., & Choti, M. A. (2008). Expanding Criteria for Resectability of Colorectal Liver Metastases. The Oncologist. https://doi.org/10.1634/theoncologist.2007-0142
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.